发明名称 低酸素活性化型プロドラッグを用いるがんの処置
摘要 <p>Cancer can be treated by administration of a hypoxia-activated prodrug, such as TH-302, alone or in combination with other anticancer agents and/or radiation therapy. In combination therapy, the hypoxia-activated prodrug and another anticancer agent or radiation therapy may be administered within the same 24-hour period, and administration of the hypoxia-activated prodrug may be completed prior to beginning administration of the other anticancer agent or radiation therapy.</p>
申请公布号 JP5765634(B2) 申请公布日期 2015.08.19
申请号 JP20110533309 申请日期 2009.10.21
申请人 发明人
分类号 A61K31/675;A61K31/282;A61K31/336;A61K31/337;A61K31/513;A61K31/519;A61K31/7068;A61K47/10;A61K47/16;A61K47/34;A61P35/00 主分类号 A61K31/675
代理机构 代理人
主权项
地址